Dr. Sui Ziye is our executive Director and the chief executive officer of our Company, a director of Miracogen Shanghai, a director of Taizhou Aoke, an executive director of CtM Bio, and the general manager of Lepu Beijing. In addition, Dr. Sui also serves as a director of Hangzhou HealSun, a company owned by us as to 23.2% . Dr. Sui has nearly ten years of managerial experience in the pharmaceutical sector.

Prior to joining our Group, Dr. Sui held several positions at Lepu Medical and its subsidiaries, including an international sales & marketing manager and a vice president of Lepu Medical, a CEO of Comed BV, a CEO of Beijing Lepu Hushengtang Technology Co., Ltd. (北京樂普護生堂網絡科技有限公司), an executive director of Beijing Star GK Medical Device Co., Ltd. (北京思達醫用裝置有限公司), the chairman of the board of Zhongcheng Healthcare Industrial (Hainan) Co., Ltd. (中鋮健康產業(海南)股份有限公司), previously known as Hainan Mingshengda Pharmaceutical Co., Ltd. (海南明盛達藥業有限公司), and a director of Beijing Quinovare Medical Technology Co., Ltd. (北京快舒爾醫療技術有限公司).

Dr. Sui obtained a bachelor’s degree in medical science from Peking University (北京大學) in the PRC in 2001 and a doctoral degree from University of Rochester in the U.S. in 2007.